Table 7.
Median regression model of RBD (receptor-binding domain) IgG BAU/ml prior to second dose
| Univariable |
Multivariable |
|||
|---|---|---|---|---|
| β (95% CI) | p | β (95% CI) | p | |
| Age 70+ | −56.8 (−65, −47) | <0.0001 | −44.2 (−53.8, −32.7) | <0.0001 |
| Female or non-binary | 14.8 (8.08, 21.9) | 0.00053 | 5.76 (1.42, 11) | 0.044 |
| Cardiovascular Disease | −26.3 (−31, −18.4) | <0.0001 | −4.16 (−8.84, 2.92) | 0.19 |
| Cancer | −19.3 (−27.2, −14.3) | <0.0001 | −9.2 (−13.1, −3.67) | 0.00062 |
| Diabetes | −21.6 (−27.4, −15.7) | <0.0001 | −6.53 (−9.94, −2.08) | 0.048 |
| Transplant or Immunosuppressed | −18.4 (−29, −6.75) | 0.0030 | −9.42 (−19.1, 0.017) | 0.057 |
| BMI (per +10) | −4.87 (−8.59, 1.29) | 0.17 | 0.32 (−4.37, 3.36) | 0.92 |
| Ever had positive COVID test | 49.6 (21.7, 1454) | 0.54 | 44.8 (1.37, 1661) | 0.16 |
| 1st Dose was mRNA-1273 | 127 (95.9, 179) | <0.0001 | 117 (78.3, 158) | <0.0001 |
| White | −26.3 (−41.4, −16.5) | 0.00032 | n/a | |
BMI, body mass index; CI, confidence interval; n/a, not applicable; RBD, receptor-binding domain.